Validation of the 4P's Plus screen for substance use in pregnancy validation of the 4P's Plus
- PMID: 17805340
- DOI: 10.1038/sj.jp.7211823
Validation of the 4P's Plus screen for substance use in pregnancy validation of the 4P's Plus
Abstract
Objective: The purpose of this study is to validate the 4P's Plus screen for substance use in pregnancy.
Study design: A total of 228 pregnant women enrolled in prenatal care underwent screening with the 4P's Plus and received a follow-up clinical assessment for substance use. Statistical analyses regarding reliability, sensitivity, specificity, and positive and negative predictive validity of the 4Ps Plus were conducted.
Result: The overall reliability for the five-item measure was 0.62. Seventy-four (32.5%) of the women had a positive screen. Sensitivity and specificity were very good, at 87 and 76%, respectively. Positive predictive validity was low (36%), but negative predictive validity was quite high (97%). Of the 31 women who had a positive clinical assessment, 45% were using less than 1 day per week.
Conclusion: The 4P's Plus reliably and effectively screens pregnant women for risk of substance use, including those women typically missed by other perinatal screening methodologies.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical